Adhesion Barrier Market Research Report - Forecast till 2027

Adhesion Barrier Market Research Report: By Product (Synthetic Adhesion Barriers (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol), Natural Adhesion Barriers (Collagen & Protein, Fibrin)), Formulation (Film, Gel, Liquid), Severity (Mild Adhesion, Severe Adhesion), Application (Gynecological Surgeries, General/Abdominal Surgeries, Orthopedic Surgeries, Cardiovascular Surgeries, Neurological Surgeries, Urological Surgeries, Reconstructive Surgeries) - Forecast till 2027

ID: MRFR/HC/7328-HCR | February, 2021 | Region : Global

Adhesion Barrier Market Overview


Adhesion Barrier Market is expected to register a CAGR of 7.32% during the forecast period from 2019 to 2025 and anticipated to reach USD 928.78 million by 2025. Adhesion barrier is a medical implant used for patients enduring abdominal or pelvic laparotomy as an adjunct intended to lessen the occurrence of postoperative adhesions between the abdominal wall and the under-lying viscera. 


The adhesion barrier market is expected to grow at a steady growth rate. Major factors influencing the growth of the adhesion barrier market include increasing surgical procedures for small bowel obstruction, infertility, & chronic pelvic pain, and cost-effective prevention of adhesions among others.  


The risk for using adhesion barrier in patients with a history of hypersensitivity and choice of using adhesion barriers among surgeons have been major factors hampering the growth of the adhesion barrier market.  


Adhesion Barrier Market Drivers



  • Increasing abdominal surgeries

    • The majority of the laparoscopy procedures lead to adhesions. It is estimated that annually in the United States more than 400,000 laparotomies are performed for small bowel obstruction

    • In the US, it is found that obstetricians-gynecologists perform two of the most common surgical procedures including cesarean delivery and abdominal hysterectomy, that is associated with a risk of developing pelvic adhesions. There has been increasing adoption of adhesions barrier products to prevent pelvic adhesions and thus contributing to the adhesion barrier market growth

    • According to a study it was found that adhesions occur in about 97% of abdominal interventions causing chronic pain, infertility, and intestinal obstruction





  • Cost-effective prevention of adhesions

    • In open surgery, adhesion barrier decreases the surgery cost compared to no adhesion barrier i.e., USD 4,376 versus USD 4,482

    • In the US, a four-year study was conducted, and it was found that the average cost of colorectal surgery was reduced to USD 106, from USD 4,482, without an adhesion barrier to USD 4,376 with an adhesion barrier.




Market Challenges



  • The risk of using adhesion barrier in patients with a history of hypersensitivity

  • Choice of using adhesion barriers among surgeons


Adhesion Barrier Market Segmentation


By Product



  • Synthetic Adhesion Barriers: The synthetic adhesion barriers are further segmented into hyaluronic acid, regenerated cellulose, and polyethylene glycol, among others. Synthetic adhesion barriers accounted for major market share owing to various advantages over natural adhesion barriers, including high biocompatibility, bioresorbable property, and cost-effectiveness of these products.



  • Natural Adhesion Barriers: Thee natural adhesion barriers are further segmented into collagen & protein, fibrin.


By Formulation



  • Film: Film based adhesion barriers are estimated to hold the largest market share, owing to better handling characteristics and proven positive results. There are major manufacturers for these products, such as J&J, Sanofi, and others.



  • Gel: Gel-based adhesion barriers are composed of polyethylene oxide and sodium carboxymethylcellulose, with protective activity.



  • Liquid: Liquid-based adhesion barriers are intended to create a site-specific barrier on a target


By Severity



  • Mild Adhesion: Mild adhesion accounted for the largest market share. According to a study out of 122 patients, it was found that only three patients shifted from mild to severe adhesion. Example of mild adhesion includes filmy and avascular



  • Severe Adhesion: Severe adhesion is estimated to hold the least market share. Example of severe adhesion includes organized, cohesive, vascular, and dense


By Application



  • Gynecological Surgeries: Gynecological surgeries are estimated to hold the largest market share owing to a large number of gynecological procedures and a huge number of women tend to develop adhesions post surgeries. It is estimated that 90% of the patients undergo key abdominal surgery and among this 55 % to 100% of females undergo pelvic surgery develop adhesions


Adhesion Barrier Market By Region



  • Americas: The Americas headed the Adhesion Barrier Market in 2019 and is likely to continue to command the market during the forecast period. This is attributed to the presence of a large number of medical device companies, rising research and development, increasing laparoscopy procedures, and the presence of a large number of the patient population to adhesion. Alone in the US, more than 400,000 laparotomies are performed for small bowel obstruction annually.



  • Europe: The region is projected to hold the second-largest share owing to increasing utilization of advanced products, and increasing development of products by existing manufacturers



  • Asia-Pacific: Asia-Pacific region is expected to grow at the fastest growth rate during the study period. This is attributed to the hugely populated countries like China, India, Indonesia, Pakistan, and Bangladesh, rising gynecological procedures, and increasing government programs for awareness of women related diseases


Key Development



  • In December 2019, Baxter International confirmed that it would acquire Sanofi's surgical products unit Seprafilm and related assets for USD 350 million in cash. The deal is expected to close in the first quarter of 2020.



  • In October 2018, FzioMed announced a new anti-adhesion product Oxiplex/IU, adhesion barrier gel for intrauterine surgery.


Adhesion Barrier Market Key Players



  • Johnson & Johnson

  • Anika Therapeutics

  • Atrium Medical Corporation (A Part of Getinge Group)

  • Baxter International

  • Betatech Medical

  • R. Bard

  • FzioMed

  • Innocoll Holdings

  • Integra LifeSciences Holdings Corporation

  • MAST Biosurgery

  • Normedi Nordic.

  • Sanofi

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL ADHESION BARRIER MARKET, BY PRODUCT

6.1. Overview

6.2. Synthetic Adhesion Barriers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Hyaluronic Acid

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Regenerated Cellulose

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Polyethylene Glycol

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Natural Adhesion Barriers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Collagen & Protein

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Fibrin

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Other

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL ADHESION BARRIER MARKET, BY FORMULATION

7.1. Overview

7.2. Film

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Gel

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Liquid

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL ADHESION BARRIER MARKET, BY PRODUCT OF SEVERITY

8.1. Overview

8.2. Mild Adhesion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Severe Adhesion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL ADHESION BARRIER MARKET, BY PRODUCT OF APPLICATION

9.1. Overview

9.2. Gynecological Surgeries

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3. General/Abdominal Surgeries

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4. Orthopedic Surgeries

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.5. Cardiovascular Surgeries

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.6. Neurological Surgeries

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.7. Urological Surgeries

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.8. Reconstructive Surgeries

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.9. Other

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10. GLOBAL ADHESION BARRIER MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Adhesion Barrier Market

11.5. Competitive Benchmarking

11.6. Leading Players in terms of Number of Developments in the Global Adhesion Barrier Market

11.7. Key developments and Growth Strategies

11.7.1. New Application Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix & Market Ratio

11.8.1. Sales & Operating Income 2020

11.8.2. Major Players R&D Expenditure 2020

11.9. Major Players Capital Market Ratio

12. COMPANY PROFILES

12.1. Johnson & Johnson.

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Key Developments

12.1.4. SWOT Analysis

12.1.5. Key Strategies

12.2. Anika Therapeutics

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Key Developments

12.2.4. SWOT Analysis

12.2.5. Key Strategies

12.3. Atrium Medical Corporation

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Key Developments

12.3.4. SWOT Analysis

12.3.5. Key Strategies

12.4. Baxter International

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Key Developments

12.4.4. SWOT Analysis

12.4.5. Key Strategies

12.5. Betatech Medical

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Key Developments

12.5.4. SWOT Analysis

12.5.5. Key Strategies

12.6. C. R. Bard

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Key Developments

12.6.4. SWOT Analysis

12.6.5. Key Strategies

12.7. FzioMed

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Key Developments

12.7.4. SWOT Analysis

12.7.5. Key Strategies

12.8. Innocoll Holdings

12.8.1. Company Overview

12.8.2. Financial Overview

12.8.3. Key Developments

12.8.4. SWOT Analysis

12.8.5. Key Strategies

12.9. Integra LifeSciences Holdings Corporation

12.9.1. Company Overview

12.9.2. Financial Overview

12.9.3. Key Developments

12.9.4. SWOT Analysis

12.9.5. Key Strategies

12.10. MAST Biosurgery

12.10.1. Company Overview

12.10.2. Financial Overview

12.10.3. Key Developments

12.10.4. SWOT Analysis

12.10.5. Key Strategies

12.11. Normedi Nordic.

12.11.1. Company Overview

12.11.2. Financial Overview

12.11.3. Key Developments

12.11.4. SWOT Analysis

12.11.5. Key Strategies

12.12. Sanofi

12.12.1. Company Overview

12.12.2. Financial Overview

12.12.3. Key Developments

12.12.4. SWOT Analysis

12.12.5. Key Strategies

12.13. Others

13. APPENDIX

13.1. References

13.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL ADHESION BARRIER MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL ADHESION BARRIER MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 7 GLOBAL ADHESION BARRIER MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 10 NORTH AMERICA: ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 11 NORTH AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 12 US: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 13 US: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 14 US: ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 15 US: ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 16 CANADA: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 17 CANADA: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 18 CANADA: ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 19 CANADA: ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 20 LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 21 LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 22 LATIN AMERICA ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 23 LATIN AMERICA ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 24 EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 25 EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 26 EUROPE ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 27 EUROPE ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 30 WESTERN EUROPE ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 31 WESTERN EUROPE ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 34 EASTERN EUROPE ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 35 EASTERN EUROPE ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION, 2020-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA ADHESION BARRIER MARKET, BY SEVERITY, 2020-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA ADHESION BARRIER MARKET, BY APPLICATION, 2020-2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCES

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ADHESION BARRIER MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ADHESION BARRIER MARKET

FIGURE 4 GLOBAL ADHESION BARRIER MARKET SHARE, BY PRODUCT, 2020 (%)

FIGURE 5 GLOBAL ADHESION BARRIER MARKET SHARE, BY FORMULATION, 2020 (%)

FIGURE 6 GLOBAL ADHESION BARRIER MARKET SHARE, BY SEVERITY, 2020 (%)

FIGURE 7 GLOBAL ADHESION BARRIER MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 8 GLOBAL ADHESION BARRIER MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: ADHESION BARRIER MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: ADHESION BARRIER MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: ADHESION BARRIER MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: ADHESION BARRIER MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: ADHESION BARRIER MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL ADHESION BARRIER MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 JOHNSON & JOHNSON: KEY FINANCIALS

FIGURE 16 JOHNSON & JOHNSON: SWOT

FIGURE 17 ANIKA THERAPEUTICS.: KEY FINANCIALS

FIGURE 18 ANIKA THERAPEUTICS.: SWOT

FIGURE 19 ATRIUM MEDICAL CORPORATION.: KEY FINANCIALS

FIGURE 20 ATRIUM MEDICAL CORPORATION.: SWOT

FIGURE 21 BAXTER INTERNATIONAL.: KEY FINANCIALS

FIGURE 22 BAXTER INTERNATIONAL.: SWOT

FIGURE 23 C. R. BARD.: KEY FINANCIALS

FIGURE 24 C. R. BARD.: SWOT

FIGURE 25 FZIOMED: KEY FINANCIALS

FIGURE 26 FZIOMED: SWOT

FIGURE 27 INNOCOLL HOLDINGS: KEY FINANCIALS

FIGURE 28 INNOCOLL HOLDINGS: SWOT

FIGURE 29 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY FINANCIALS

FIGURE 30 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: SWOT

FIGURE 31 MAST BIOSURGERY: KEY FINANCIALS

FIGURE 32 MAST BIOSURGERY: SWOT

FIGURE 33 NORMEDI NORDIC.: KEY FINANCIALS

FIGURE 34 NORMEDI NORDIC.: SWOT

FIGURE 35 SANOFI: KEY FINANCIALS

FIGURE 36 SANOFI: SWOT



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.